Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram
Central Excise - Tariff - Notifications

Home Notifications 1989 Central Excise Central Excise - 1989 Central Excise - Tariff Miscellaneous Exemptions This

Exemption to formulations of Rifampicin - 141/89 - Central Excise - Tariff

  • Contents

Exemption to formulations of Rifampicin

Notification No. 141/89-C.E.

Dated 16-5-1989

In exercise of the powers conferred by sub-section (1) of section 5A of the Central Excises and Salt Act, 1944 (1 of 1944), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts single ingredient formulations of Rifampicin and formulations of Rifampicin with Isoniazid (INH), and falling under heading No. 30.03 of the Schedule to the Central Excise Tariff Act, 1985 (5 of 1986), from the whole of the duty of excise leviable thereon, which is specified in the said Schedule.

Explanation : For the purposes of this notification,-

(a) the expression "formulations of Rifampicin with Isoniazid (INH)" means medicaments processed out of or containing the bulk drugs Rifampicin and Isoniazid (INH) with or without the use of any pharmaceutical aids (such as diluent, disintegrating agent, moistening agent, lubricant, buffering agent, stabiliser or preserver) which are therapeutically inert and do not interfere with therapeutic or prophylactic activity of the drugs for internal or external use for, or in the diagnosis, treatment, mitigation or prevention of disease in human beings or animals, but does not include any substance to which the provisions of the Drugs and Cosmetics Act, 1940 (23 of 1940) do not apply.

(b) the expression "single ingredient formulations of Rifampicin" means medicaments processed out of Rifampicin bulk drug with or without the use of any pharmaceutical aids (such as diluent, disintegrating agent, moistening agent, lubricant, buffering agent, stabiliser or preserver) which are therapeutically inert and do not interfere with therapeutic or prophylactic activity of the drug for internal or external use for, or in the diagnosis, treat­ment, mitigation or prevention of disease in human beings or animals, but does not include any substance to which the provisions of the Drugs and Cosmetics Act, 1940 (23 of 1940) do not apply.

(c) the expression "bulk drug" has the same meaning as assigned to it in the Drugs (Prices Control) Order, 1987.

 
 

 

Quick Updates:Latest Updates